| Product Code: ETC7647337 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Carbapenem Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Carbapenem Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Carbapenem Market - Industry Life Cycle |
3.4 Israel Carbapenem Market - Porter's Five Forces |
3.5 Israel Carbapenem Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Carbapenem Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Carbapenem Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Carbapenem Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing awareness about the benefits of carbapenem antibiotics |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of carbapenem drugs |
4.3.2 Concerns regarding antibiotic resistance and overuse |
4.3.3 High cost associated with carbapenem medications |
5 Israel Carbapenem Market Trends |
6 Israel Carbapenem Market, By Types |
6.1 Israel Carbapenem Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Carbapenem Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Carbapenem Market Revenues & Volume, By Meropenem, 2021- 2031F |
6.1.4 Israel Carbapenem Market Revenues & Volume, By Imipenem, 2021- 2031F |
6.1.5 Israel Carbapenem Market Revenues & Volume, By Ertapenem, 2021- 2031F |
6.2 Israel Carbapenem Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Carbapenem Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Israel Carbapenem Market Revenues & Volume, By Bloodstream Infections, 2021- 2031F |
6.2.4 Israel Carbapenem Market Revenues & Volume, By Intra-abdominal Infections, 2021- 2031F |
6.2.5 Israel Carbapenem Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.3 Israel Carbapenem Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Carbapenem Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Carbapenem Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 Israel Carbapenem Market Import-Export Trade Statistics |
7.1 Israel Carbapenem Market Export to Major Countries |
7.2 Israel Carbapenem Market Imports from Major Countries |
8 Israel Carbapenem Market Key Performance Indicators |
8.1 Rate of antibiotic-resistant bacterial infections in Israel |
8.2 Number of healthcare facilities adopting carbapenem antibiotics |
8.3 Research and development investments in new carbapenem formulations |
8.4 Patient adherence and compliance to carbapenem therapy |
8.5 Government initiatives promoting the rational use of antibiotics |
9 Israel Carbapenem Market - Opportunity Assessment |
9.1 Israel Carbapenem Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Carbapenem Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Carbapenem Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Carbapenem Market - Competitive Landscape |
10.1 Israel Carbapenem Market Revenue Share, By Companies, 2024 |
10.2 Israel Carbapenem Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here